GNRH1 and precocious puberty: Because of early puberty (not fulfilling the criteria of precocious puberty) and/or moderate bone age advancement, four male survivors were treated with GnRH-analog (n = 2) or letrozole (n = 2) in an attempt to delay epiphyseal closure and maximize the final height (Table 2).